We are live on ! Find out more
T. Rowe Price Associates

T. Rowe Price Associates Portfolio holdings

AUM $865B
1-Year Est. Return 30.76%
 

T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.

This Fund
S&P 500
This Quarter Est. Return
+5.24%
1 Year Est. Return
+30.76%
3 Year Est. Return
+117.39%
5 Year Est. Return
+143.85%
10 Year Est. Return
+1,089.89%
AUM
$463B
AUM Growth
+$17.5B
Cap. Flow
-$1.61B
Cap. Flow %
-0.35%
Top 10 Hldgs %
12.49%
Holding
2,596
New
97
Increased
1,091
Reduced
793
Closed
67

Sector Composition

Rank Sector Weight
1 Healthcare 16.64%
2 Consumer Discretionary 13.46%
3 Financials 12.79%
4 Industrials 12.13%
5 Technology 9.46%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
YOKU
701
DELISTED
YOUKU TUDOU INC.(CAYMAN ISLS)
YOKU
$80.7M 0.02%
3,380,243
-6,332,028
-65% -$142M
EA
702
DELISTED
Electronic Arts
EA
$80.5M 0.02%
2,243,735
+1,749,113
+354% +$56.8M
CCMP
703
DELISTED
CMC Materials, Inc. Common Stock
CCMP
$80.4M 0.02%
1,801,116
+40,300
+2% +$1.75M
PIR
704
DELISTED
Pier 1 Imports, Inc.
PIR
$80.4M 0.02%
260,771
+49,231
+23% +$17.3M
ESI icon
705
Element Solutions
ESI
$9.51B
$80.2M 0.02%
2,861,535
+2,657,235
+1,301% +$61.8M
MCF
706
DELISTED
Contango Oil & Gas Co.
MCF
$80M 0.02%
1,889,915
+1,610
+0.1% +$71.7K
ARMH
707
DELISTED
ARM HOLDINGS PLC ADS
ARMH
$79.8M 0.02%
1,763,050
+1,600
+0.1% +$74.3K
KNGT
708
DELISTED
KNIGHT TRANSPORTATION INC
KNGT
$78.8M 0.02%
3,313,387
-41,220
-1% -$980K
BAP icon
709
Credicorp
BAP
$29.8B
$77.7M 0.02%
499,554
-33,633
-6% -$5.04M
EXXI
710
DELISTED
ENERGY XXI LTD COM SHS
EXXI
$77.3M 0.02%
3,273,389
+399,469
+14% +$9.01M
BFS
711
Saul Centers
BFS
$865M
$77.2M 0.02%
1,587,664
+31,850
+2% +$1.51M
HUB.B
712
DELISTED
HUBBELL INC CL-B
HUB.B
$77.1M 0.02%
626,098
-31,746
-5% -$3.76M
TSRO
713
DELISTED
TESARO, Inc.
TSRO
$77M 0.02%
2,474,339
+702,186
+40% +$18.7M
SPSC icon
714
SPS Commerce
SPSC
$2.86B
$76.3M 0.02%
2,415,600
+663,600
+38% +$18.6M
CEB
715
DELISTED
CEB Inc.
CEB
$76.3M 0.02%
1,118,018
-161,777
-13% -$11.1M
SONC
716
DELISTED
Sonic Corp
SONC
$76.1M 0.02%
3,447,137
-84,920
-2% -$1.79M
KAMN
717
DELISTED
Kaman Corp
KAMN
$75.9M 0.02%
1,777,342
+2,175
+0.1% +$90.7K
SYNA icon
718
Synaptics
SYNA
$4.2B
$75.5M 0.02%
833,465
+15,450
+2% +$1.05M
CIR
719
DELISTED
CIRCOR International, Inc
CIR
$75.5M 0.02%
979,260
+10,830
+1% +$837K
EQY
720
DELISTED
Equity One
EQY
$75.2M 0.02%
3,187,271
-61,124
-2% -$1.39M
FRGI
721
DELISTED
Fiesta Restaurant Group, Inc.
FRGI
$75.2M 0.02%
1,619,900
+64,700
+4% +$2.61M
PHH
722
DELISTED
PHH Corporation
PHH
$75M 0.02%
3,264,666
+3,245,600
+17,023% +$77M
HSNI
723
DELISTED
HSN, Inc.
HSNI
$74.9M 0.02%
1,264,374
-190,790
-13% -$10.8M
GG
724
DELISTED
Goldcorp Inc
GG
$74.6M 0.02%
2,672,022
+3,674
+0.1% +$91.2K
HTWR
725
DELISTED
HEARTWARE INTERNATIONAL INC COM STK (DE)
HTWR
$74.5M 0.02%
841,591
-15,900
-2% -$1.42M

Similar funds

T. Rowe Price Associates's Q2 2014 Portfolio in Review

As of Q2 2014, T. Rowe Price Associates held 2,596 positions worth $463B, up 3.9% from $445B the previous quarter. Its ten largest holdings account for 12% of the portfolio.

T. Rowe Price Associates's Q2 2014 filing shows 97 new, 1,091 increased, 793 reduced and 67 closed positions. Its largest new stake was Teva Pharmaceuticals: 4,638,481 shares worth $243M. The largest sale was Procter & Gamble, an estimated $1.4B.

By sector, the portfolio is most concentrated in Healthcare at 17% of assets, up from 16% a quarter earlier, followed by Consumer Discretionary and Financials.

  • T. Rowe Price Associates's largest Q2 2014 buy was Teva Pharmaceuticals: 4,638,481 shares worth $243M.
  • T. Rowe Price Associates added most to Allergan Inc in Q2 2014, an estimated $1.3B increase.
  • T. Rowe Price Associates's biggest Q2 2014 reduction was Procter & Gamble, cutting an estimated $1.4B.
  • T. Rowe Price Associates fully exited Santander in Q2 2014, selling an estimated $134M.
  • T. Rowe Price Associates's ten largest holdings make up 12% of its $463B portfolio in Q2 2014.
  • T. Rowe Price Associates opened 97 new positions and closed 67 in Q2 2014.
  • T. Rowe Price Associates's portfolio value rose 3.9% quarter-over-quarter to $463B.

Based on T. Rowe Price Associates's 13F filing for Q2 2014, filed 14 Aug 2014.